trending Market Intelligence /marketintelligence/en/news-insights/trending/rowextonc9rtrlzovgyndw2 content esgSubNav
In This List

Scythian Biosciences to list on Nasdaq Capital Market

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery


Scythian Biosciences to list on Nasdaq Capital Market

Scythian Biosciences Corp. received approval to list its common shares on the Nasdaq Capital Market.

The company's common shares will trade on Nasdaq under the symbol SCYB, starting Feb. 22.